<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-05-30" modified="2020-10-07" version="203">
<accession>O95863</accession>
<accession>B2R842</accession>
<accession>Q9P113</accession>
<accession>Q9UBP7</accession>
<accession>Q9UHH7</accession>
<name>SNAI1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Zinc finger protein SNAI1</fullName>
</recommendedName>
<alternativeName>
<fullName>Protein snail homolog 1</fullName>
<shortName>Protein sna</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">SNAI1</name>
<name type="synonym">SNAH</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2001" name="Cancer Res." volume="61" first="1338" last="1346">
<title>Down-regulation of promoter 1.3 activity of the human aromatase gene in breast tissue by zinc-finger protein, snail (SnaH).</title>
<authorList>
<person name="Okubo T."/>
<person name="Truong T.K."/>
<person name="Yu B."/>
<person name="Itoh T."/>
<person name="Zhao J."/>
<person name="Grube B."/>
<person name="Zhou D."/>
<person name="Chen S."/>
</authorList>
<dbReference type="PubMed" id="11245431"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT ALA-118</scope>
<source>
<tissue>Mammary gland</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Hum. Genet." volume="105" first="320" last="326">
<title>Characterisation of the human snail (SNAI1) gene and exclusion as a major disease gene in craniosynostosis.</title>
<authorList>
<person name="Twigg S.R."/>
<person name="Wilkie A.O.M."/>
</authorList>
<dbReference type="PubMed" id="10543399"/>
<dbReference type="DOI" id="10.1007/s004399900143"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="Genomics" volume="62" first="42" last="49">
<title>Genomic organization, expression, and chromosome location of the human SNAIL gene (SNAI1) and a related processed pseudogene (SNAI1P).</title>
<authorList>
<person name="Paznekas W.A."/>
<person name="Okajima K."/>
<person name="Schertzer M."/>
<person name="Wood S."/>
<person name="Jabs E.W."/>
</authorList>
<dbReference type="PubMed" id="10585766"/>
<dbReference type="DOI" id="10.1006/geno.1999.6010"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Teratocarcinoma</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2001" name="Nature" volume="414" first="865" last="871">
<title>The DNA sequence and comparative analysis of human chromosome 20.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Matthews L.H."/>
<person name="Ashurst J.L."/>
<person name="Burton J."/>
<person name="Gilbert J.G.R."/>
<person name="Jones M."/>
<person name="Stavrides G."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beard L.M."/>
<person name="Beare D.M."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Buck D."/>
<person name="Burrill W.D."/>
<person name="Butler A.P."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clamp M."/>
<person name="Clark G."/>
<person name="Clark L.N."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V.E."/>
<person name="Collier R.E."/>
<person name="Connor R.E."/>
<person name="Corby N.R."/>
<person name="Coulson A."/>
<person name="Coville G.J."/>
<person name="Deadman R."/>
<person name="Dhami P.D."/>
<person name="Dunn M."/>
<person name="Ellington A.G."/>
<person name="Frankland J.A."/>
<person name="Fraser A."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Gwilliam R."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Heath P.D."/>
<person name="Ho S."/>
<person name="Holden J.L."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Jekosch K."/>
<person name="Johnson C.M."/>
<person name="Johnson D."/>
<person name="Kay M.P."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lehvaeslaiho M.H."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J.D."/>
<person name="Marsh V.L."/>
<person name="Martin S.L."/>
<person name="McConnachie L.J."/>
<person name="McLay K."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mistry D."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Nickerson T."/>
<person name="Oliver K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce T.A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Prathalingam S.R."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Sycamore N."/>
<person name="Taylor R."/>
<person name="Tee L."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A.C."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whitehead S.L."/>
<person name="Whittaker P."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Hubbard T."/>
<person name="Durbin R.M."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="11780052"/>
<dbReference type="DOI" id="10.1038/414865a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2000" name="Nat. Cell Biol." volume="2" first="84" last="89">
<title>The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells.</title>
<authorList>
<person name="Batlle E."/>
<person name="Sancho E."/>
<person name="Franci C."/>
<person name="Dominguez D."/>
<person name="Monfar M."/>
<person name="Baulida J."/>
<person name="Garcia de Herreros A."/>
</authorList>
<dbReference type="PubMed" id="10655587"/>
<dbReference type="DOI" id="10.1038/35000034"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-172</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Nat. Cell Biol." volume="6" first="931" last="940">
<title>Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition.</title>
<authorList>
<person name="Zhou B.P."/>
<person name="Deng J."/>
<person name="Xia W."/>
<person name="Xu J."/>
<person name="Li Y.M."/>
<person name="Gunduz M."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="15448698"/>
<dbReference type="DOI" id="10.1038/ncb1173"/>
</citation>
<scope>INTERACTION WITH GSK3B AND BTRC</scope>
<scope>PHOSPHORYLATION AT SER-96; SER-100; SER-104; SER-107; SER-111; SER-115 AND SER-119 BY GSK3B</scope>
<scope>UBIQUITINATION BY BTRC</scope>
<scope>MUTAGENESIS OF SER-96; SER-100; SER-107; SER-111; SER-115 AND SER-119</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="3179" last="3184">
<title>Pak1 phosphorylation of snail, a master regulator of epithelial-to-mesenchyme transition, modulates snail's subcellular localization and functions.</title>
<authorList>
<person name="Yang Z."/>
<person name="Rayala S."/>
<person name="Nguyen D."/>
<person name="Vadlamudi R.K."/>
<person name="Chen S."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="15833848"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-04-3480"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-246 BY PAK1</scope>
<scope>MUTAGENESIS OF SER-246</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="EMBO J." volume="24" first="3446" last="3458">
<title>A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression.</title>
<authorList>
<person name="Peinado H."/>
<person name="Del Carmen Iglesias-de la Cruz M."/>
<person name="Olmeda D."/>
<person name="Csiszar K."/>
<person name="Fong K.S."/>
<person name="Vega S."/>
<person name="Nieto M.A."/>
<person name="Cano A."/>
<person name="Portillo F."/>
</authorList>
<dbReference type="PubMed" id="16096638"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600781"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH LOXL2 AND LOXL3</scope>
<scope>MUTAGENESIS OF LYS-9; LYS-16; LYS-98 AND LYS-137</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="Genes Cells" volume="10" first="455" last="464">
<title>Zinc finger domain of Snail functions as a nuclear localization signal for importin beta-mediated nuclear import pathway.</title>
<authorList>
<person name="Yamasaki H."/>
<person name="Sekimoto T."/>
<person name="Ohkubo T."/>
<person name="Douchi T."/>
<person name="Nagata Y."/>
<person name="Ozawa M."/>
<person name="Yoneda Y."/>
</authorList>
<dbReference type="PubMed" id="15836774"/>
<dbReference type="DOI" id="10.1111/j.1365-2443.2005.00850.x"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH KPNB1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="11740" last="11748">
<title>Wnt-dependent regulation of the E-cadherin repressor snail.</title>
<authorList>
<person name="Yook J.I."/>
<person name="Li X.Y."/>
<person name="Ota I."/>
<person name="Fearon E.R."/>
<person name="Weiss S.J."/>
</authorList>
<dbReference type="PubMed" id="15647282"/>
<dbReference type="DOI" id="10.1074/jbc.m413878200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH GSK3B AND BTRC</scope>
<scope>PHOSPHORYLATION AT SER-104 AND SER-107</scope>
<scope>MUTAGENESIS OF SER-96; SER-104 AND SER-107</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Dev. Cell" volume="14" first="424" last="436">
<title>Ajuba LIM proteins are snail/slug corepressors required for neural crest development in Xenopus.</title>
<authorList>
<person name="Langer E.M."/>
<person name="Feng Y."/>
<person name="Zhaoyuan H."/>
<person name="Rauscher F.J. III"/>
<person name="Kroll K.L."/>
<person name="Longmore G.D."/>
</authorList>
<dbReference type="PubMed" id="18331720"/>
<dbReference type="DOI" id="10.1016/j.devcel.2008.01.005"/>
</citation>
<scope>INTERACTION WITH LIMD1 AND AJUBA</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="J. Cell Sci." volume="122" first="1452" last="1460">
<title>Characterization of Snail nuclear import pathways as representatives of C2H2 zinc finger transcription factors.</title>
<authorList>
<person name="Mingot J.M."/>
<person name="Vega S."/>
<person name="Maestro B."/>
<person name="Sanz J.M."/>
<person name="Nieto M.A."/>
</authorList>
<dbReference type="PubMed" id="19386897"/>
<dbReference type="DOI" id="10.1242/jcs.041749"/>
</citation>
<scope>INTERACTION WITH KPNA2; KPNB1; TNPO1 AND IPO7</scope>
<scope>MUTAGENESIS OF 151-ARG-LYS-152; CYS-156; LYS-161; LYS-170; CYS-182; LYS-187; ARG-191; CYS-210; ARG-215; ARG-220; ASN-222; ARG-224; 232-ASP--LYS-235; CYS-238 AND GLN-239</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2010" name="EMBO J." volume="29" first="1803" last="1816">
<title>The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1.</title>
<authorList>
<person name="Lin Y."/>
<person name="Wu Y."/>
<person name="Li J."/>
<person name="Dong C."/>
<person name="Ye X."/>
<person name="Chi Y.I."/>
<person name="Evers B.M."/>
<person name="Zhou B.P."/>
</authorList>
<dbReference type="PubMed" id="20389281"/>
<dbReference type="DOI" id="10.1038/emboj.2010.63"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH KDM1A</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF PRO-2; ARG-3; SER-4; PHE-5; ARG-8 AND LYS-9</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="EMBO J." volume="29" first="3787" last="3796">
<title>Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition.</title>
<authorList>
<person name="Park S.Y."/>
<person name="Kim H.S."/>
<person name="Kim N.H."/>
<person name="Ji S."/>
<person name="Cha S.Y."/>
<person name="Kang J.G."/>
<person name="Ota I."/>
<person name="Shimada K."/>
<person name="Konishi N."/>
<person name="Nam H.W."/>
<person name="Hong S.W."/>
<person name="Yang W.H."/>
<person name="Roth J."/>
<person name="Yook J.I."/>
<person name="Cho J.W."/>
</authorList>
<dbReference type="PubMed" id="20959806"/>
<dbReference type="DOI" id="10.1038/emboj.2010.254"/>
</citation>
<scope>GLYCOSYLATION AT SER-112</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="FEBS J." volume="277" first="1202" last="1218">
<title>Snail associates with EGR-1 and SP-1 to upregulate transcriptional activation of p15INK4b.</title>
<authorList>
<person name="Hu C.T."/>
<person name="Chang T.Y."/>
<person name="Cheng C.C."/>
<person name="Liu C.S."/>
<person name="Wu J.R."/>
<person name="Li M.C."/>
<person name="Wu W.S."/>
</authorList>
<dbReference type="PubMed" id="20121949"/>
<dbReference type="DOI" id="10.1111/j.1742-4658.2009.07553.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EGR1</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="FEBS Lett." volume="584" first="2231" last="2236">
<title>p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma.</title>
<authorList>
<person name="Lim S.O."/>
<person name="Kim H."/>
<person name="Jung G."/>
</authorList>
<dbReference type="PubMed" id="20385133"/>
<dbReference type="DOI" id="10.1016/j.febslet.2010.04.006"/>
</citation>
<scope>INTERACTION WITH TP53 AND MDM2</scope>
<scope>UBIQUITINATION BY MDM2</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="3794" last="3805">
<title>The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation.</title>
<authorList>
<person name="Vinas-Castells R."/>
<person name="Beltran M."/>
<person name="Valls G."/>
<person name="Gomez I."/>
<person name="Garcia J.M."/>
<person name="Montserrat-Sentis B."/>
<person name="Baulida J."/>
<person name="Bonilla F."/>
<person name="de Herreros A.G."/>
<person name="Diaz V.M."/>
</authorList>
<dbReference type="PubMed" id="19955572"/>
<dbReference type="DOI" id="10.1074/jbc.m109.065995"/>
</citation>
<scope>UBIQUITINATION BY FBXL14 AND BTRC</scope>
<scope>INTERACTION WITH FBXL14</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-98; LYS-137 AND LYS-146</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Mol. Biol. Cell" volume="21" first="244" last="253">
<title>Phosphorylation of serine 11 and serine 92 as new positive regulators of human Snail1 function: potential involvement of casein kinase-2 and the cAMP-activated kinase protein kinase A.</title>
<authorList>
<person name="MacPherson M.R."/>
<person name="Molina P."/>
<person name="Souchelnytskyi S."/>
<person name="Wernstedt C."/>
<person name="Martin-Perez J."/>
<person name="Portillo F."/>
<person name="Cano A."/>
</authorList>
<dbReference type="PubMed" id="19923321"/>
<dbReference type="DOI" id="10.1091/mbc.e09-06-0504"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>INTERACTION WITH CSNK2A1</scope>
<scope>PHOSPHORYLATION AT SER-11; SER-82; SER-92; SER-104 AND SER-107</scope>
<scope>MUTAGENESIS OF SER-11; SER-92; SER-104 AND SER-107</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Oncogene" volume="29" first="3124" last="3133">
<title>Role of CK1 in GSK3beta-mediated phosphorylation and degradation of snail.</title>
<authorList>
<person name="Xu Y."/>
<person name="Lee S.H."/>
<person name="Kim H.S."/>
<person name="Kim N.H."/>
<person name="Piao S."/>
<person name="Park S.H."/>
<person name="Jung Y.S."/>
<person name="Yook J.I."/>
<person name="Park B.J."/>
<person name="Ha N.C."/>
</authorList>
<dbReference type="PubMed" id="20305697"/>
<dbReference type="DOI" id="10.1038/onc.2010.77"/>
</citation>
<scope>INTERACTION WITH CSNK1E</scope>
<scope>PHOSPHORYLATION BY CSNK1E AND GSK3B</scope>
<scope>PHOSPHORYLATION AT SER-96</scope>
<scope>MUTAGENESIS OF SER-96; SER-100; SER-104 AND SER-107</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="Oncogene" volume="29" first="4896" last="4904">
<title>Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition.</title>
<authorList>
<person name="Lin T."/>
<person name="Ponn A."/>
<person name="Hu X."/>
<person name="Law B.K."/>
<person name="Lu J."/>
</authorList>
<dbReference type="PubMed" id="20562920"/>
<dbReference type="DOI" id="10.1038/onc.2010.234"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH KDM1A</scope>
<scope>MUTAGENESIS OF PRO-2</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="BMC Biol." volume="9" first="83" last="83">
<title>Notch1 binds and induces degradation of Snail in hepatocellular carcinoma.</title>
<authorList>
<person name="Lim S.O."/>
<person name="Kim H.S."/>
<person name="Quan X."/>
<person name="Ahn S.M."/>
<person name="Kim H."/>
<person name="Hsieh D."/>
<person name="Seong J.K."/>
<person name="Jung G."/>
</authorList>
<dbReference type="PubMed" id="22128911"/>
<dbReference type="DOI" id="10.1186/1741-7007-9-83"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>INTERACTION WITH NOTCH1 AND MDM2</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION BY MDM2</scope>
<scope>MUTAGENESIS OF SER-96 AND SER-100</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="15126" last="15131">
<title>Importin alpha protein acts as a negative regulator for Snail protein nuclear import.</title>
<authorList>
<person name="Sekimoto T."/>
<person name="Miyamoto Y."/>
<person name="Arai S."/>
<person name="Yoneda Y."/>
</authorList>
<dbReference type="PubMed" id="21454664"/>
<dbReference type="DOI" id="10.1074/jbc.m110.213579"/>
</citation>
<scope>INTERACTION WITH KPNB1; KPNA1; KPNA4 AND KPNA2</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="Oncogene" volume="30" first="4365" last="4372">
<title>Poly(ADP-ribose)-dependent regulation of Snail1 protein stability.</title>
<authorList>
<person name="Rodriguez M.I."/>
<person name="Gonzalez-Flores A."/>
<person name="Dantzer F."/>
<person name="Collard J."/>
<person name="de Herreros A.G."/>
<person name="Oliver F.J."/>
</authorList>
<dbReference type="PubMed" id="21577210"/>
<dbReference type="DOI" id="10.1038/onc.2011.153"/>
</citation>
<scope>INTERACTION WITH PARP1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ADP-RIBOSYLATION BY PARP1</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2012" name="EMBO J." volume="31" first="29" last="43">
<title>Lats2 kinase potentiates Snail1 activity by promoting nuclear retention upon phosphorylation.</title>
<authorList>
<person name="Zhang K."/>
<person name="Rodriguez-Aznar E."/>
<person name="Yabuta N."/>
<person name="Owen R.J."/>
<person name="Mingot J.M."/>
<person name="Nojima H."/>
<person name="Nieto M.A."/>
<person name="Longmore G.D."/>
</authorList>
<dbReference type="PubMed" id="21952048"/>
<dbReference type="DOI" id="10.1038/emboj.2011.357"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT THR-203 BY LATS2</scope>
<scope>MUTAGENESIS OF THR-203</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2016" name="Oncogene" volume="35" first="389" last="401">
<title>Syntenin regulates TGF-beta1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-beta type I receptor internalization.</title>
<authorList>
<person name="Hwangbo C."/>
<person name="Tae N."/>
<person name="Lee S."/>
<person name="Kim O."/>
<person name="Park O.K."/>
<person name="Kim J."/>
<person name="Kwon S.H."/>
<person name="Lee J.H."/>
</authorList>
<dbReference type="PubMed" id="25893292"/>
<dbReference type="DOI" id="10.1038/onc.2015.100"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="29" evidence="1">
<citation type="journal article" date="2011" name="Structure" volume="19" first="212" last="220">
<title>Molecular mimicry and ligand recognition in binding and catalysis by the histone demethylase LSD1-CoREST complex.</title>
<authorList>
<person name="Baron R."/>
<person name="Binda C."/>
<person name="Tortorici M."/>
<person name="McCammon J.A."/>
<person name="Mattevi A."/>
</authorList>
<dbReference type="PubMed" id="21300290"/>
<dbReference type="DOI" id="10.1016/j.str.2011.01.001"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 2-21 IN COMPLEX WITH KDM1A</scope>
<scope>INTERACTION WITH KDM1A</scope>
<scope>DOMAIN</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2014" name="Acta Crystallogr. D" volume="70" first="1050" last="1060">
<title>Structural basis for the selective nuclear import of the C2H2 zinc-finger protein Snail by importin beta.</title>
<authorList>
<person name="Choi S."/>
<person name="Yamashita E."/>
<person name="Yasuhara N."/>
<person name="Song J."/>
<person name="Son S.Y."/>
<person name="Won Y.H."/>
<person name="Hong H.R."/>
<person name="Shin Y.S."/>
<person name="Sekimoto T."/>
<person name="Park I.Y."/>
<person name="Yoneda Y."/>
<person name="Lee S.J."/>
</authorList>
<dbReference type="PubMed" id="24699649"/>
<dbReference type="DOI" id="10.1107/s1399004714000972"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) IN COMPLEX WITH ZINC AND KPNB1</scope>
<scope>INTERACTION WITH KPNB1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ARG-191; TRP-193; GLN-196; ARG-224; GLN-228 AND ARG-247</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2013" name="ACS Chem. Biol." volume="8" first="1677" last="1682">
<title>Protein recognition by short peptide reversible inhibitors of the chromatin-modifying LSD1/CoREST lysine demethylase.</title>
<authorList>
<person name="Tortorici M."/>
<person name="Borrello M.T."/>
<person name="Tardugno M."/>
<person name="Chiarelli L.R."/>
<person name="Pilotto S."/>
<person name="Ciossani G."/>
<person name="Vellore N.A."/>
<person name="Bailey S.G."/>
<person name="Cowan J."/>
<person name="O'Connell M."/>
<person name="Crabb S.J."/>
<person name="Packham G."/>
<person name="Mai A."/>
<person name="Baron R."/>
<person name="Ganesan A."/>
<person name="Mattevi A."/>
</authorList>
<dbReference type="PubMed" id="23721412"/>
<dbReference type="DOI" id="10.1021/cb4001926"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 2-7 IN COMPLEX WITH KDM1A</scope>
<scope>INTERACTION WITH KDM1A</scope>
<scope>FUNCTION</scope>
</reference>
<comment type="function">
<text evidence="4 6 9 12 17 20 21 23 26 28">Involved in induction of the epithelial to mesenchymal transition (EMT), formation and maintenance of embryonic mesoderm, growth arrest, survival and cell migration. Binds to 3 E-boxes of the E-cadherin/CDH1 gene promoter and to the promoters of CLDN7 and KRT8 and, in association with histone demethylase KDM1A which it recruits to the promoters, causes a decrease in dimethylated H3K4 levels and represses transcription (PubMed:20389281, PubMed:20562920). The N-terminal SNAG domain competes with histone H3 for the same binding site on the histone demethylase complex formed by KDM1A and RCOR1, and thereby inhibits demethylation of histone H3 at 'Lys-4' (in vitro) (PubMed:20389281, PubMed:21300290, PubMed:23721412). During EMT, involved with LOXL2 in negatively regulating pericentromeric heterochromatin transcription (By similarity). SNAI1 recruits LOXL2 to pericentromeric regions to oxidize histone H3 and repress transcription which leads to release of heterochromatin component CBX5/HP1A, enabling chromatin reorganization and acquisition of mesenchymal traits (By similarity). Associates with EGR1 and SP1 to mediate tetradecanoyl phorbol acetate (TPA)-induced up-regulation of CDKN2B, possibly by binding to the CDKN2B promoter region 5'-TCACA-3. In addition, may also activate the CDKN2B promoter by itself.</text>
</comment>
<comment type="subunit">
<text evidence="3 8 9 10 11 12 13 14 15 16 17 18 19 20 21 23 24 25 27 28 29">Interacts with FBXL14 and GSK3B. Interacts with BTRC; interaction occurs when it is phosphorylated on the destruction motif. Interacts (via SNAG domain) with WTIP (via LIM domains) (By similarity). Interacts (via SNAG domain) with LIMD1 (via LIM domains), and AJUBA (via LIM domains). Interacts with LOXL2 and LOXL3. Interacts (via N-terminal region) with CSNK2A1. Interacts with EGR1 upon TPA induction. Interacts (via N-terminal region) with LATS2; the interaction is dependent on LATS2 kinase activity but independent of SNAI1 Thr-203 phosphorylation. Interacts (via zinc fingers) with KPNB1 and TNPO1; the interactions mediate nuclear import. Interacts (via zinc fingers) with KPNA1; the interaction disrupts the transport complex with KPNB1 and prevents nuclear import increasing SNAI1 degradation in the cytoplasm. Interacts (via zinc fingers) with KPNA2; the interaction, in combination with KPNB1, mediates nuclear import. Interacts with KPNA4; this interaction mediates nuclear import. May interact (via zinc fingers) with IPO7. Interacts (via zinc fingers) with PARP1; the interaction requires SNAI1 to be poly-ADP-ribosylated and non-phosphorylated (active) by GSK3B. Interacts (via SNAG domain) with KDM1A (PubMed:20389281, PubMed:20562920, PubMed:21300290, PubMed:23721412). Interaction with KDM1A is necessary for the down-regulation of dimethylated H3K4 mark and promoter activity of E-cadherin/CDH1, CDN7 and KRT8 (PubMed:20389281, PubMed:20562920). Interacts with TP53/p53 and (via zinc fingers) with NOTCH1 (via intracellular domain); the interactions induce SNAI1 degradation via MDM2-mediated ubiquitination and inhibit SNAI1-induced cell invasion. Interacts with MDM2; the interaction promotes SNAI1 ubiquitination. Interacts (via zinc fingers) with CSNK1E. Interacts with PAK1 (PubMed:15833848).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-77797">
<id>P35609</id>
<label>ACTN2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-2880652">
<id>Q08043</id>
<label>ACTN3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-949782">
<id>Q96IF1</id>
<label>AJUBA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-307461">
<id>Q9Y297</id>
<label>BTRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-3866319">
<id>Q9Y2V7</id>
<label>COG6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-81215">
<id>Q92793</id>
<label>CREBBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-743105">
<id>Q5JVL4</id>
<label>EFHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-447295">
<id>Q09472</id>
<label>EP300</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-371922">
<id>Q96B26</id>
<label>EXOSC8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-6425532">
<id>Q8N1E6</id>
<label>FBXL14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-1047804">
<id>Q86XK2</id>
<label>FBXO11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-701903">
<id>Q14192</id>
<label>FHL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-726150">
<id>Q92990</id>
<label>GLMN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-5916454">
<id>A6NEM1</id>
<label>GOLGA6L9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-373586">
<id>P49841</id>
<label>GSK3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-301834">
<id>Q13547</id>
<label>HDAC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-301821">
<id>Q92769</id>
<label>HDAC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-710124">
<id>O60341</id>
<label>KDM1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>32</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-948001">
<id>Q15323</id>
<label>KRT31</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-10171697">
<id>Q6A162</id>
<label>KRT40</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-11959885">
<id>Q07627</id>
<label>KRTAP1-1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-10172526">
<id>Q9UJV3-2</id>
<label>MID2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-742948">
<id>Q5JR59</id>
<label>MTUS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-945833">
<id>Q7Z3S9</id>
<label>NOTCH2NLA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-355676">
<id>P09874</id>
<label>PARP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-357275">
<id>Q99471</id>
<label>PFDN5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-73886">
<id>Q04206</id>
<label>RELA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-714146">
<id>O14543</id>
<label>SOCS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-2659201">
<id>Q96BD6</id>
<label>SPSB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-355744">
<id>Q12933</id>
<label>TRAF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-740098">
<id>P36406</id>
<label>TRIM23</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-924214">
<id>Q9C035</id>
<label>TRIM5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-742327">
<id>Q15654</id>
<label>TRIP6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-296306">
<id>P45481</id>
<label>Crebbp</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045459">
<id>O95863</id>
</interactant>
<interactant intactId="EBI-397697">
<id>P63085</id>
<label>Mapk1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8 10 20 29 30">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="8 10">Cytoplasm</location>
</subcellularLocation>
<text evidence="8">Once phosphorylated (probably on Ser-107, Ser-111, Ser-115 and Ser-119) it is exported from the nucleus to the cytoplasm where subsequent phosphorylation of the destruction motif and ubiquitination involving BTRC occurs.</text>
</comment>
<comment type="tissue specificity">
<text evidence="6">Expressed in a variety of tissues with the highest expression in kidney. Expressed in mesenchymal and epithelial cell lines.</text>
</comment>
<comment type="induction">
<text evidence="17">Induced by TPA maximally by 2.5-fold at 4 hours, in HepG2 cells (at protein level).</text>
</comment>
<comment type="PTM">
<text evidence="9 15 18 32">Phosphorylated by GSK3B. Once phosphorylated, it becomes a target for BTRC ubiquitination. Phosphorylation by CSNK1E, probably at Ser-104, provides the priming site for the subsequent phosphorylation by GSK3B, probably at Ser-100 and Ser-96. Phosphorylation by PAK1 may modulate its transcriptional activity by promoting increased accumulation in the nucleus. Phosphorylation at Ser-11 and Ser-92 positively regulates its functions in induction of EMT and cell survival, respectively. Phosphorylation by LATS2, upon mitotic stress, oncogenic stress or Hippo pathway activation, occurs in the nucleus and promotes nuclear retention and stabilization of total cellular protein level.</text>
</comment>
<comment type="PTM">
<text>Ubiquitinated on Lys-98, Lys-137 and Lys-146 by FBXL14 and BTRC leading to degradation. BTRC-triggered ubiquitination requires previous GSK3B-mediated SNAI1 phosphorylation. Ubiquitination induced upon interaction with NOTCH1 or TP53/p53 is mediated by MDM2.</text>
</comment>
<comment type="PTM">
<text>O-GlcNAcylation at Ser-112 is enhanced in hyperglycaemic conditions, it opposes phosphorylation by GSK3B, and stabilizes the protein.</text>
</comment>
<comment type="PTM">
<text>ADP-ribosylation by PARP1 increases protein half-life and may be involved in TGFB-induced SNAI1 up-regulation.</text>
</comment>
<comment type="similarity">
<text evidence="31">Belongs to the snail C2H2-type zinc-finger protein family.</text>
</comment>
<comment type="caution">
<text evidence="35">The interaction with mouse KPNA2 may prevent SNAI1 nuclear import.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/SNAI1ID452ch20q13.html"/>
</comment>
<dbReference type="EMBL" id="AF125377">
<property type="protein sequence ID" value="AAD17332.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ245657">
<property type="protein sequence ID" value="CAB52414.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ245658">
<property type="protein sequence ID" value="CAB52414.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ245659">
<property type="protein sequence ID" value="CAB52414.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF155233">
<property type="protein sequence ID" value="AAD52986.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF177731">
<property type="protein sequence ID" value="AAD52996.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK313228">
<property type="protein sequence ID" value="BAG36039.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL121712">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC012910">
<property type="protein sequence ID" value="AAH12910.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF131208">
<property type="protein sequence ID" value="AAF32527.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13423.1"/>
<dbReference type="RefSeq" id="NP_005976.2">
<property type="nucleotide sequence ID" value="NM_005985.3"/>
</dbReference>
<dbReference type="PDB" id="2Y48">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="C=2-21"/>
</dbReference>
<dbReference type="PDB" id="3W5K">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="B=1-264"/>
</dbReference>
<dbReference type="PDB" id="3ZMT">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="C=2-7"/>
</dbReference>
<dbReference type="PDB" id="4QLI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="B=175-180"/>
</dbReference>
<dbReference type="PDBsum" id="2Y48"/>
<dbReference type="PDBsum" id="3W5K"/>
<dbReference type="PDBsum" id="3ZMT"/>
<dbReference type="PDBsum" id="4QLI"/>
<dbReference type="SMR" id="O95863"/>
<dbReference type="BioGRID" id="112499">
<property type="interactions" value="476"/>
</dbReference>
<dbReference type="CORUM" id="O95863"/>
<dbReference type="DIP" id="DIP-50870N"/>
<dbReference type="IntAct" id="O95863">
<property type="interactions" value="68"/>
</dbReference>
<dbReference type="MINT" id="O95863"/>
<dbReference type="STRING" id="9606.ENSP00000244050"/>
<dbReference type="GlyGen" id="O95863">
<property type="glycosylation" value="1 site"/>
</dbReference>
<dbReference type="iPTMnet" id="O95863"/>
<dbReference type="PhosphoSitePlus" id="O95863"/>
<dbReference type="SwissPalm" id="O95863"/>
<dbReference type="BioMuta" id="SNAI1"/>
<dbReference type="EPD" id="O95863"/>
<dbReference type="jPOST" id="O95863"/>
<dbReference type="MassIVE" id="O95863"/>
<dbReference type="PaxDb" id="O95863"/>
<dbReference type="PeptideAtlas" id="O95863"/>
<dbReference type="PRIDE" id="O95863"/>
<dbReference type="ProteomicsDB" id="51096"/>
<dbReference type="Antibodypedia" id="3135">
<property type="antibodies" value="849 antibodies"/>
</dbReference>
<dbReference type="CPTC" id="O95863">
<property type="antibodies" value="1 antibody"/>
</dbReference>
<dbReference type="DNASU" id="6615"/>
<dbReference type="Ensembl" id="ENST00000244050">
<property type="protein sequence ID" value="ENSP00000244050"/>
<property type="gene ID" value="ENSG00000124216"/>
</dbReference>
<dbReference type="GeneID" id="6615"/>
<dbReference type="KEGG" id="hsa:6615"/>
<dbReference type="UCSC" id="uc002xuz.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6615"/>
<dbReference type="DisGeNET" id="6615"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000124216.3"/>
<dbReference type="GeneCards" id="SNAI1"/>
<dbReference type="HGNC" id="HGNC:11128">
<property type="gene designation" value="SNAI1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000124216">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="604238">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O95863"/>
<dbReference type="OpenTargets" id="ENSG00000124216"/>
<dbReference type="PharmGKB" id="PA35977"/>
<dbReference type="eggNOG" id="KOG2462">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000154681"/>
<dbReference type="HOGENOM" id="CLU_002678_42_3_1"/>
<dbReference type="InParanoid" id="O95863"/>
<dbReference type="KO" id="K05707"/>
<dbReference type="OMA" id="EGYVAFP"/>
<dbReference type="OrthoDB" id="1318335at2759"/>
<dbReference type="PhylomeDB" id="O95863"/>
<dbReference type="TreeFam" id="TF315515"/>
<dbReference type="PathwayCommons" id="O95863"/>
<dbReference type="Reactome" id="R-HSA-8943724">
<property type="pathway name" value="Regulation of PTEN gene transcription"/>
</dbReference>
<dbReference type="SIGNOR" id="O95863"/>
<dbReference type="BioGRID-ORCS" id="6615">
<property type="hits" value="10 hits in 894 CRISPR screens"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O95863"/>
<dbReference type="GeneWiki" id="SNAI1"/>
<dbReference type="GenomeRNAi" id="6615"/>
<dbReference type="Pharos" id="O95863">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O95863"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 20"/>
</dbReference>
<dbReference type="RNAct" id="O95863">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000124216">
<property type="expression patterns" value="Expressed in left coronary artery and 137 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="O95863">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005721">
<property type="term" value="C:pericentric heterochromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070888">
<property type="term" value="F:E-box binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019900">
<property type="term" value="F:kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003180">
<property type="term" value="P:aortic valve morphogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060536">
<property type="term" value="P:cartilage morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016477">
<property type="term" value="P:cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001837">
<property type="term" value="P:epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003198">
<property type="term" value="P:epithelial to mesenchymal transition involved in endocardial cushion formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031069">
<property type="term" value="P:hair follicle morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070828">
<property type="term" value="P:heterochromatin organization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060972">
<property type="term" value="P:left/right pattern formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001707">
<property type="term" value="P:mesoderm formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060806">
<property type="term" value="P:negative regulation of cell differentiation involved in embryonic placenta development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043518">
<property type="term" value="P:negative regulation of DNA damage response, signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902230">
<property type="term" value="P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010957">
<property type="term" value="P:negative regulation of vitamin D biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0061314">
<property type="term" value="P:Notch signaling involved in heart development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001649">
<property type="term" value="P:osteoblast differentiation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010718">
<property type="term" value="P:positive regulation of epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000810">
<property type="term" value="P:regulation of bicellular tight junction assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060021">
<property type="term" value="P:roof of mouth development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060707">
<property type="term" value="P:trophoblast giant cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="IDEAL" id="IID00363"/>
<dbReference type="InterPro" id="IPR036236">
<property type="entry name" value="Znf_C2H2_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013087">
<property type="entry name" value="Znf_C2H2_type"/>
</dbReference>
<dbReference type="Pfam" id="PF00096">
<property type="entry name" value="zf-C2H2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00355">
<property type="entry name" value="ZnF_C2H2"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57667">
<property type="entry name" value="SSF57667"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS00028">
<property type="entry name" value="ZINC_FINGER_C2H2_1"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50157">
<property type="entry name" value="ZINC_FINGER_C2H2_2"/>
<property type="match status" value="4"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0013">ADP-ribosylation</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Zinc finger protein SNAI1" id="PRO_0000047029">
<location>
<begin position="1"/>
<end position="264"/>
</location>
</feature>
<feature type="zinc finger region" description="C2H2-type 1" evidence="5">
<location>
<begin position="154"/>
<end position="176"/>
</location>
</feature>
<feature type="zinc finger region" description="C2H2-type 2" evidence="5">
<location>
<begin position="178"/>
<end position="202"/>
</location>
</feature>
<feature type="zinc finger region" description="C2H2-type 3" evidence="5">
<location>
<begin position="208"/>
<end position="230"/>
</location>
</feature>
<feature type="zinc finger region" description="C2H2-type 4; atypical" evidence="5">
<location>
<begin position="236"/>
<end position="259"/>
</location>
</feature>
<feature type="region of interest" description="SNAG domain" evidence="33 34">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="region of interest" description="Required and sufficient for interaction with KDM1A" evidence="20 28">
<location>
<begin position="2"/>
<end position="7"/>
</location>
</feature>
<feature type="region of interest" description="LATS2 binding">
<location>
<begin position="10"/>
<end position="40"/>
</location>
</feature>
<feature type="region of interest" description="Required for FBXL14-triggered degradation">
<location>
<begin position="120"/>
<end position="151"/>
</location>
</feature>
<feature type="region of interest" description="Required for nuclear localization and interaction with KPNB1, NOTCH1 and PARP1" evidence="25 27">
<location>
<begin position="151"/>
<end position="264"/>
</location>
</feature>
<feature type="short sequence motif" description="Destruction motif">
<location>
<begin position="95"/>
<end position="100"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ser-rich">
<location>
<begin position="90"/>
<end position="120"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKA" evidence="15">
<location>
<position position="11"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="82"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2" evidence="15">
<location>
<position position="92"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18 32">
<location>
<position position="96"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="32">
<location>
<position position="100"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 15 32">
<location>
<position position="104"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 15 32">
<location>
<position position="107"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="32">
<location>
<position position="111"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="32">
<location>
<position position="115"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="32">
<location>
<position position="119"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by LATS2" evidence="26">
<location>
<position position="203"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PAK1" evidence="10">
<location>
<position position="246"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) serine" evidence="22">
<location>
<position position="112"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)">
<location>
<position position="98"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)">
<location>
<position position="137"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)">
<location>
<position position="146"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34261470." id="VAR_069162">
<original>A</original>
<variation>V</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4647958." id="VAR_019969" evidence="7">
<original>V</original>
<variation>A</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes repressor activity on E-cadherin/CDH1 promoter and binding to KDM1A." evidence="20 21">
<original>P</original>
<variation>A</variation>
<location>
<position position="2"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with KDM1A." evidence="20">
<original>R</original>
<variation>A</variation>
<location>
<position position="3"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with KDM1A." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="4"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with KDM1A." evidence="20">
<original>F</original>
<variation>A</variation>
<location>
<position position="5"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with KDM1A." evidence="20">
<original>R</original>
<variation>A</variation>
<location>
<position position="8"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with KDM1A." evidence="20">
<original>K</original>
<variation>A</variation>
<location>
<position position="9"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect E-cadherin/CDH1 repression; when associated with R-16." evidence="12">
<original>K</original>
<variation>R</variation>
<location>
<position position="9"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes PKA phosphorylation. Strongly decreases repressor activity on E-cadherin/CDH1 and CLDN1 promoters. Increases protein stability. Affects function in EMT." evidence="15">
<original>S</original>
<variation>A</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect E-cadherin repression; when associated with R-9." evidence="12">
<original>K</original>
<variation>R</variation>
<location>
<position position="16"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes CK2 phosphorylation. Strongly decreases repressor activity on E-cadherin/CDH1 and CLDN1 promoters. Increases protein stability. Affects function in cell survival. Abolishes phosphorylation in the serine-rich region; when associated with A-104 and A-107." evidence="15">
<original>S</original>
<variation>A</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect repressor activity on E-cadherin/CDH1 promoter." evidence="15">
<original>S</original>
<variation>E</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes recognition and ubiquitination by BTRC which increases steady state level and half-life. Preferentially localizes to the nucleus. Induces a more aggressive tissue invasion program. Lower sensitivity to BTRC-triggered degradation, impairs phosphorylation by GSK3B and does not affect NOTCH1-induced degradation; when associated with A-100. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-100; A-107; A-111; A-115 and A-119." evidence="8 9 18 27">
<original>S</original>
<variation>A</variation>
<location>
<position position="96"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change. Complete loss of sensitivity to FBXL14- and BTRC-triggered degradation and loss of ability to repress E-cadherin/CDH1; when associated with R-137 and R-146." evidence="12 16">
<original>K</original>
<variation>R</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="mutagenesis site" description="Lower sensitivity to BTRC-triggered degradation and impaired phosphorylation by GSK3B; when associated with A-96. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-96; A-107; A-111; A-115 and A-119. Does not affect NOTCH1-induced degradation; when associated with A-96. Abolishes phosphorylation at S-96." evidence="8 18 27">
<original>S</original>
<variation>A</variation>
<location>
<position position="100"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases protein stability, does not affect repressor activity on E-cadherin/CDH1 promoter, preferentially localizes to the nucleus, induces a more aggressive tissue invasion program and impairs phosphorylation by GSK3B, binding to BTRC and ubiquitination; when associated with A-107. Impairs phosphorylation in the serine-rich domain/region; when associated with A-92 and A-107. Abolishes phosphorylation at S-96." evidence="9 15 18">
<original>S</original>
<variation>A</variation>
<location>
<position position="104"/>
</location>
</feature>
<feature type="mutagenesis site" description="Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-111; A-115 and A-119. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-96; A-100; A-111; A-115 and A-119. Increases protein stability, does not affect repressor activity on E-cadherin promoter, preferentially localizes to the nucleus, induces a more aggressive tissue invasion program and impairs phosphorylation by GSK3B, binding to BTRC and ubiquitination; when associated with A-104. Impairs phosphorylation in the serine-rich region; when associated with A-92 and A-104. Abolishes phosphorylation at S-96." evidence="8 9 15 18">
<original>S</original>
<variation>A</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="mutagenesis site" description="Predominantly localized to the cytoplasm; when associated with E-111; E-115 and E-119." evidence="8 9 15 18">
<original>S</original>
<variation>E</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="mutagenesis site" description="Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-107; A-115 and A-119. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-96; A-100; A-107; A-115 and A-119." evidence="8">
<original>S</original>
<variation>A</variation>
<location>
<position position="111"/>
</location>
</feature>
<feature type="mutagenesis site" description="Predominantly localized to the cytoplasm; when associated with E-107; E-115 and E-119." evidence="8">
<original>S</original>
<variation>E</variation>
<location>
<position position="111"/>
</location>
</feature>
<feature type="mutagenesis site" description="Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-107; A-111 and A-119. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-96; A-100; A-107; A-111 and A-119." evidence="8">
<original>S</original>
<variation>A</variation>
<location>
<position position="115"/>
</location>
</feature>
<feature type="mutagenesis site" description="Predominantly localized to the cytoplasm; when associated with E-107; E-111 and E-119." evidence="8">
<original>S</original>
<variation>E</variation>
<location>
<position position="115"/>
</location>
</feature>
<feature type="mutagenesis site" description="Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-107; A-111 and A-119. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-96; A-100; A-107; A-111 and A-115." evidence="8">
<original>S</original>
<variation>A</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="mutagenesis site" description="Predominantly localized to the cytoplasm; when associated with E-107; E-111 and E-115." evidence="8">
<original>S</original>
<variation>E</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="mutagenesis site" description="Lower sensitivity to FBXL14-triggered degradation. Lower sensitivity to FBXL14-triggered degradation; when associated with R-146. Complete loss of sensitivity to FBXL14- and BTRC-triggered degradation and loss of ability to repress E-cadherin; when associated with R-98 and R-146." evidence="12 16">
<original>K</original>
<variation>R</variation>
<location>
<position position="137"/>
</location>
</feature>
<feature type="mutagenesis site" description="Lower sensitivity to FBXL14-triggered degradation. Lower sensitivity to FBXL14-triggered degradation; when associated with R-137. Complete loss of sensitivity to FBXL14- and BTRC-triggered degradation; when associated with R-98 and R-137." evidence="16">
<original>K</original>
<variation>R</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1." evidence="14">
<original>RK</original>
<variation>EE</variation>
<location>
<begin position="151"/>
<end position="152"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to KPNB1, KPNA2, IPO7 and TNPO1 and nuclear localization." evidence="14">
<original>C</original>
<variation>A</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1 and abolishes nuclear localization, DNA binding and repressor activity on E-cadherin/CDH1 promoter; when associated with E-170. Abolishes binding to KPNB1, KPNA2, IPO7 and TNPO1 and nuclear localization; when associated with E-187 and/or E-220." evidence="14">
<original>K</original>
<variation>E</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1 and abolishes nuclear localization, DNA binding and repressor activity on E-cadherin/CDH1 promoter; when associated with E-161." evidence="14">
<original>K</original>
<variation>E</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs binding to KPNB1, IPO7 and TNPO1 and abolishes binding to KPNA2. Localizes to cytoplasm and nucleus." evidence="14">
<original>C</original>
<variation>A</variation>
<location>
<position position="182"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1 and abolishes nuclear localization, DNA binding and repressor activity on E-cadherin/CDH1 promoter; when associated with E-191. Abolishes binding to KPNB1, KPNA2, IPO7 and TNPO1 and nuclear localization; when associated with E-161 and/or E-220." evidence="14">
<original>K</original>
<variation>E</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mildly reduces binding to KPNB1 and nuclear import. Strongly reduces binding to KPNB1 and nuclear import; when associated with A-193. Loss of binding to KPNB1 and nuclear import; when associated with A-193 and A-196." evidence="29">
<original>R</original>
<variation>E</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mildly reduces binding to KPNB1. Does not affect binding to KPNA2, IPO7 or TNPO1." evidence="14">
<original>R</original>
<variation>E</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mildly reduces binding to KPNB1 and nuclear import. Strongly reduces binding to KPNB1 and nuclear import; when associated with E-191. Loss of binding to KPNB1 and nuclear import; when associated with E-191 and A-196." evidence="29">
<original>W</original>
<variation>A</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of binding to KPNB1 and nuclear import; when associated with E-191 and A-193." evidence="29">
<original>Q</original>
<variation>A</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes LATS2 phosphorylation. Does not affect binding to LATS2. Reduces protein stability. Equally distributed between nucleus and cytoplasm. Increases capacity to associate with nuclear pore importins. Unable to accumulate in the nucleus. Does not abrogate function." evidence="26">
<original>T</original>
<variation>A</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="mutagenesis site" description="Exclusively localizes to the cytoplasm. Reduces capacity to associate with nuclear pore importins. Unable to enter the nucleus. Does not abrogate function." evidence="26">
<original>T</original>
<variation>E</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs binding to KPNB1, IPO7 and TNPO1 and abolishes binding to KPNA2. Localizes to cytoplasm and nucleus." evidence="14">
<original>C</original>
<variation>A</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1. No change in subcellular localization." evidence="14">
<original>R</original>
<variation>E</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1; when associated with E-222 and E-224. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1 and abolishes nuclear localization, DNA binding and repressor activity on E-cadherin/CDH1 promoter; when associated with E-224. Abolishes binding to KPNB1, KPNA2, IPO7 and TNPO1 and nuclear localization; when associated with E-161 and/or E-187." evidence="14">
<original>R</original>
<variation>E</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1; when associated with E-220 and E-224." evidence="14">
<original>N</original>
<variation>E</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1; when associated with E-220 and E-222. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1 and abolishes nuclear localization, DNA binding and repressor activity on E-cadherin/CDH1 promoter; when associated with E-220." evidence="14">
<original>R</original>
<variation>E</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mildly reduces binding to KPNB1 and nuclear import. Strongly reduces binding to KPNB1 and nuclear import; when associated with A-228." evidence="29">
<original>R</original>
<variation>E</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="mutagenesis site" description="Very minor effect on binding to KPNB1 and nuclear import. Strongly reduces binding to KPNB1 and nuclear import; when associated with E-224." evidence="29">
<original>Q</original>
<variation>A</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1." evidence="14">
<original>DVKK</original>
<variation>KVEE</variation>
<location>
<begin position="232"/>
<end position="235"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs binding to KPNB1 and IPO7 and abolishes binding to KPNA2 and TNPO1 and nuclear localization." evidence="14">
<original>C</original>
<variation>A</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect binding to KPNB1, KPNA2, IPO7, TNPO1 or DNA." evidence="14">
<original>Q</original>
<variation>E</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases repression activity on E-cadherin/CDH1, occludin and aromatase promoters. Preferentially localizes to the cytoplasm. Abolishes phosphorylation by PAK1." evidence="10">
<original>S</original>
<variation>A</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mildly reduces binding to KPNB1 and nuclear import." evidence="29">
<original>R</original>
<variation>E</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAG36039." ref="4" evidence="31">
<original>P</original>
<variation>L</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAF32527." ref="7" evidence="31">
<original>F</original>
<variation>S</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="3"/>
<end position="5"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="157"/>
<end position="159"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="163"/>
<end position="165"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="166"/>
<end position="173"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="174"/>
<end position="176"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="183"/>
<end position="185"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="188"/>
<end position="191"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="192"/>
<end position="200"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="211"/>
<end position="213"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="216"/>
<end position="219"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="220"/>
<end position="227"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="239"/>
<end position="241"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="244"/>
<end position="247"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="248"/>
<end position="256"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2Y48"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3W5K"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q02085"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00042"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10655587"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11245431"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15448698"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15647282"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15833848"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15836774"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16096638"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18331720"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19386897"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19923321"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19955572"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20121949"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20305697"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20385133"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20389281"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20562920"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20959806"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21300290"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21454664"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21577210"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21952048"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22128911"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23721412"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24699649"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25893292"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000305"/>
<evidence key="32" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="15448698"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20389281"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21300290"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21454664"/>
</source>
</evidence>
<sequence length="264" mass="29083" checksum="70E298C9BB154115" modified="2000-12-01" version="2">MPRSFLVRKPSDPNRKPNYSELQDSNPEFTFQQPYDQAHLLAAIPPPEILNPTASLPMLIWDSVLAPQAQPIAWASLRLQESPRVAELTSLSDEDSGKGSQPPSPPSPAPSSFSSTSVSSLEAEAYAAFPGLGQVPKQLAQLSEAKDLQARKAFNCKYCNKEYLSLGALKMHIRSHTLPCVCGTCGKAFSRPWLLQGHVRTHTGEKPFSCPHCSRAFADRSNLRAHLQTHSDVKKYQCQACARTFSRMSLLHKHQESGCSGCPR</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

